Hantz Financial Services, Inc. Argenx Se Transaction History
Hantz Financial Services, Inc.
- $5.74 Billion
- Q4 2024
A detailed history of Hantz Financial Services, Inc. transactions in Argenx Se stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 521 shares of ARGX stock, worth $338,175. This represents 0.01% of its overall portfolio holdings.
Number of Shares
521
Previous 528
1.33%
Holding current value
$338,175
Previous $286,000
11.89%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding ARGX
# of Institutions
422Shares Held
30.5MCall Options Held
354KPut Options Held
489K-
Price T Rowe Associates Inc Baltimore, MD5.82MShares$3.78 Billion0.36% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.99 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.48MShares$1.61 Billion0.72% of portfolio
-
Capital World Investors Los Angeles, CA1.7MShares$1.1 Billion0.15% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$804 Million10.11% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.9B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...